Apellis Pharmaceuticals IncEigentümerstruktur
| Preis (2026-07-28) | 52W Hoch | 52W Tief |
| 3.0575 USD | 41,14 USD | 3,058 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 40,923 USD | 10 | 4 | 8 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 128.021.277 | 12,55 | 1,15 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Apellis Pharmaceuticals Inc
Mitarbeiter 733
Handelsplatz NASDAQ
Ticker Symbol APLS
IPO Datum 2017-11-09
Adresse 100 Fifth Avenue, Waltham, MA, United States, 02451
Webseite https://apellis.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Cedric Francois M.D., Ph.D. | Co-Founder, President, CEO & Director |
| 2 | Mr. Alec Machiels J.D., MBA | Co-Founder & Director |
| 3 | Mr. Timothy E. Sullivan | CFO & Treasurer |
| 4 | Mr. David O. Watson Esq., J.D. | General Counsel & Secretary |
| 5 | Ms. Kelley Boucher | Chief People Officer |
| 6 | Dr. Caroline R. Baumal M.D. | Chief Medical Officer |
| 7 | Dr. Pascal Deschatelets Ph.D. | Co-Founder & Chief Scientific Officer |
| 8 | Mr. James G. Chopas CPA | VP, Corporate Controller & Chief Accounting Officer |
| 9 | Ms. Eva Stroynowski | Head of Investor Relations |
| 10 | Prof. Peter Hillmen M.D., Ph.D. | Head of Hematology Engagement & Member of PNH Scientific Advisory Board |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | venBio Select Advisor LLC | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 5 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 6 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Pentwater Capital Management LP | 0,00% | 0,00 Mio. USD |
| 9 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Deep Track Capital, LP | 0,00% | 0,00 Mio. USD |
| 11 | Point72 Asset Management, L.P. | 0,00% | 0,00 Mio. USD |
| 12 | RTW INVESTMENTS, LLC | 0,00% | 0,00 Mio. USD |
| 13 | HBK INVESTMENTS L P | 0,00% | 0,00 Mio. USD |
| 14 | Suvretta Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 15 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 16 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 17 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 18 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 19 | Balyasny Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 20 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |